Dr Reddys Laboratories (RDY) Equity Average (2023 - 2025)

Dr Reddys Laboratories (RDY) has 2 years of Equity Average data on record, last reported at $3.1 billion in Q1 2024.

  • For Q1 2024, Equity Average rose 15.8% year-over-year to $3.1 billion; the TTM value through Mar 2024 reached $3.1 billion, up 15.8%, while the annual FY2024 figure was $3.1 billion, 15.29% up from the prior year.
  • Equity Average reached $3.1 billion in Q1 2024 per RDY's latest filing, up from $2.7 billion in the prior quarter.
  • Across five years, Equity Average topped out at $3.1 billion in Q1 2024 and bottomed at $2.7 billion in Q1 2023.